Literature DB >> 27497782

MicroRNA-328, a Potential Anti-Fibrotic Target in Cardiac Interstitial Fibrosis.

Weijie Du1, Haihai Liang, Xu Gao, Xiaoxue Li, Yue Zhang, Zhenwei Pan, Cui Li, Yuying Wang, Yanxin Liu, Wei Yuan, Ning Ma, Wenfeng Chu, Hongli Shan, Yanjie Lu.   

Abstract

BACKGROUND/AIMS: Deregulated myocardial fibrosis is associated with a wide spectrum of cardiac conditions, being considered one of the major causes for heart disease. Our study was designed to investigate the role of microRNA-328 (miR-328) in regulating cardiac fibrosis.
METHODS: We induced cardiac fibrosis following MI by occlusion of the left coronary artery in C57BL/6 mice. Real-time PCR was employed to evaluate the level of miR-328. Masson's Trichrome stain was used to evaluate the development of fibrosis. Luciferase activity assay was performed to confirm the miRNA's binding site in the TGFβRIII gene. Western blot analysis was used to examine TGFβRIII, p-smad2/3 and TGF-β1 at protein level.
RESULTS: In this study, we found that miR-328 was significantly upregulated in the border zone of infarcted myocardium of wild type (WT) mice; TGFβRIII was downregulated whereas TGF-β1 was upregulated along with increased cardiac fibrosis. And miR-328 stimulated TGF-β1 signaling and promoted collagen production in cultured fibroblasts. We further found that the pro-fibrotic effect of miR-328 was mediated by targeting TGFβRIII. Additionally, cardiac fibrosis was significantly reduced in infarcted heart when treated with miR-328 antisense.
CONCLUSIONS: These data suggest that miR-328 is a potent pro-fibrotic miRNA and an important determinant of cardiac fibrosis in diseased heart.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27497782     DOI: 10.1159/000447793

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  13 in total

1.  miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells.

Authors:  Duo Li; Ke Liu; Zhiyong Li; Jian Wang; Xiaofeng Wang
Journal:  Cell Adh Migr       Date:  2017-11-13       Impact factor: 3.405

Review 2.  Epigenetic signatures in cardiac fibrosis, special emphasis on DNA methylation and histone modification.

Authors:  Hui Tao; Zheng-Yu Song; Xuan-Sheng Ding; Jing-Jing Yang; Kai-Hu Shi; Jun Li
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

Review 3.  Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?

Authors:  Ambra Vestri; Federica Pierucci; Alessia Frati; Lucia Monaco; Elisabetta Meacci
Journal:  Front Pharmacol       Date:  2017-06-02       Impact factor: 5.810

4.  MicroRNA-30c suppresses the pro-fibrogenic effects of cardiac fibroblasts induced by TGF-β1 and prevents atrial fibrosis by targeting TGFβRII.

Authors:  Juan Xu; Haiqing Wu; Songwen Chen; Baozhen Qi; Genqing Zhou; Lidong Cai; Liqun Zhao; Yong Wei; Shaowen Liu
Journal:  J Cell Mol Med       Date:  2018-03-13       Impact factor: 5.310

5.  microRNA-328 in exosomes derived from M2 macrophages exerts a promotive effect on the progression of pulmonary fibrosis via FAM13A in a rat model.

Authors:  Meng-Ying Yao; Wei-Hong Zhang; Wen-Tao Ma; Qiu-Hong Liu; Li-Hua Xing; Gao-Feng Zhao
Journal:  Exp Mol Med       Date:  2019-06-04       Impact factor: 8.718

Review 6.  Cell type-specific microRNA therapies for myocardial infarction.

Authors:  Bohao Liu; Bryan Wang; Xiaokan Zhang; Roberta Lock; Trevor Nash; Gordana Vunjak-Novakovic
Journal:  Sci Transl Med       Date:  2021-02-10       Impact factor: 17.956

7.  MicroRNA-130a, a Potential Antifibrotic Target in Cardiac Fibrosis.

Authors:  Li Li; Kelsey R Bounds; Piyali Chatterjee; Sudhiranjan Gupta
Journal:  J Am Heart Assoc       Date:  2017-11-07       Impact factor: 5.501

8.  Identification and Functional Verification of MicroRNAs in the Obese Rat With Erectile Dysfunction.

Authors:  Yunlong Bai; Liangshuan Zhang; Yanan Jiang; Jiaming Ju; Guiyang Li; Juan Xu; Xing Jiang; Peng Zhang; Linchuan Lang; Olga Sadkovaya; Peter V Glybochko; Wei Zhang; Baofeng Yang
Journal:  Sex Med       Date:  2017-09-29       Impact factor: 2.491

9.  Cardiac fibroblast-specific p38α MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism.

Authors:  Sumia A Bageghni; Karen E Hemmings; Ngonidzashe Zava; Christopher P Denton; Karen E Porter; Justin F X Ainscough; Mark J Drinkhill; Neil A Turner
Journal:  FASEB J       Date:  2018-03-30       Impact factor: 5.191

Review 10.  Exosomes: From Potential Culprits to New Therapeutic Promise in the Setting of Cardiac Fibrosis.

Authors:  Roman Tikhomirov; Benedict Reilly-O' Donnell; Francesco Catapano; Giuseppe Faggian; Julia Gorelik; Fabio Martelli; Costanza Emanueli
Journal:  Cells       Date:  2020-03-02       Impact factor: 7.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.